Efficacy of cognitive behavioral therapy for comorbid insomnia: a meta-analysis

Isa Okajima, Yuichi Inoue

    研究成果: Article

    2 引用 (Scopus)

    抄録

    Although cognitive behavioral therapy (CBT-I) has been recommended for the treatment of insomnia comorbid with psychiatric disorders and medical diseases, the effectiveness of CBT-I in such cases remains to be established. To fill this gap in the literature, we conducted a meta-analysis on the efficacy of CBT-I in the remediation of insomnia severity, important disease-related symptoms, and quality of life (QoL) in comorbid insomnia. A comprehensive literature search identified 30 randomized controlled trials (RCT) that were eligible for inclusion in the final analyses. Effect sizes were computed with Hedges’g, and study quality was evaluated using the Jadad scale. Analysis revealed that the effect sizes of the treatment were medium to large for important disease-related symptoms (g = 0.60), insomnia severity (g = 0.94), subjective and objective sleep onset latency (g = 0.65 and g = 0.51, respectively), subjective waking after sleep onset (g = 0.61), subjective and objective sleep efficiency (g = 0.83 and g = 0.48, respectively), and sleep quality (g = 0.80), but was small for health-related QoL (g = 0.34) compared with a control group. At follow-up, the effect sizes of CBT-I were large for all outcome variables, but several large and significant heterogeneities were confirmed. CBT-I is an effective treatment for reducing the severity of insomnia and important disease-related symptoms of comorbid insomnia.

    元の言語English
    ページ(範囲)21-35
    ページ数15
    ジャーナルSleep and Biological Rhythms
    16
    発行部数1
    DOI
    出版物ステータスPublished - 2018 1 1

    Fingerprint

    Sleep Initiation and Maintenance Disorders
    Cognitive Therapy
    Meta-Analysis
    Sleep
    Quality of Life
    Psychiatry
    Therapeutics
    Randomized Controlled Trials
    Control Groups

    ASJC Scopus subject areas

    • Physiology
    • Neuropsychology and Physiological Psychology
    • Neurology
    • Physiology (medical)

    これを引用

    Efficacy of cognitive behavioral therapy for comorbid insomnia : a meta-analysis. / Okajima, Isa; Inoue, Yuichi.

    :: Sleep and Biological Rhythms, 巻 16, 番号 1, 01.01.2018, p. 21-35.

    研究成果: Article

    Okajima, Isa ; Inoue, Yuichi. / Efficacy of cognitive behavioral therapy for comorbid insomnia : a meta-analysis. :: Sleep and Biological Rhythms. 2018 ; 巻 16, 番号 1. pp. 21-35.
    @article{bcae34fd35464b9987d97dfc885708c7,
    title = "Efficacy of cognitive behavioral therapy for comorbid insomnia: a meta-analysis",
    abstract = "Although cognitive behavioral therapy (CBT-I) has been recommended for the treatment of insomnia comorbid with psychiatric disorders and medical diseases, the effectiveness of CBT-I in such cases remains to be established. To fill this gap in the literature, we conducted a meta-analysis on the efficacy of CBT-I in the remediation of insomnia severity, important disease-related symptoms, and quality of life (QoL) in comorbid insomnia. A comprehensive literature search identified 30 randomized controlled trials (RCT) that were eligible for inclusion in the final analyses. Effect sizes were computed with Hedges’g, and study quality was evaluated using the Jadad scale. Analysis revealed that the effect sizes of the treatment were medium to large for important disease-related symptoms (g = 0.60), insomnia severity (g = 0.94), subjective and objective sleep onset latency (g = 0.65 and g = 0.51, respectively), subjective waking after sleep onset (g = 0.61), subjective and objective sleep efficiency (g = 0.83 and g = 0.48, respectively), and sleep quality (g = 0.80), but was small for health-related QoL (g = 0.34) compared with a control group. At follow-up, the effect sizes of CBT-I were large for all outcome variables, but several large and significant heterogeneities were confirmed. CBT-I is an effective treatment for reducing the severity of insomnia and important disease-related symptoms of comorbid insomnia.",
    keywords = "Cognitive behavioral therapy, Comorbid insomnia, Meta-analysis, Randomized controlled trial",
    author = "Isa Okajima and Yuichi Inoue",
    year = "2018",
    month = "1",
    day = "1",
    doi = "10.1007/s41105-017-0124-8",
    language = "English",
    volume = "16",
    pages = "21--35",
    journal = "Sleep and Biological Rhythms",
    issn = "1446-9235",
    publisher = "Wiley-Blackwell",
    number = "1",

    }

    TY - JOUR

    T1 - Efficacy of cognitive behavioral therapy for comorbid insomnia

    T2 - a meta-analysis

    AU - Okajima, Isa

    AU - Inoue, Yuichi

    PY - 2018/1/1

    Y1 - 2018/1/1

    N2 - Although cognitive behavioral therapy (CBT-I) has been recommended for the treatment of insomnia comorbid with psychiatric disorders and medical diseases, the effectiveness of CBT-I in such cases remains to be established. To fill this gap in the literature, we conducted a meta-analysis on the efficacy of CBT-I in the remediation of insomnia severity, important disease-related symptoms, and quality of life (QoL) in comorbid insomnia. A comprehensive literature search identified 30 randomized controlled trials (RCT) that were eligible for inclusion in the final analyses. Effect sizes were computed with Hedges’g, and study quality was evaluated using the Jadad scale. Analysis revealed that the effect sizes of the treatment were medium to large for important disease-related symptoms (g = 0.60), insomnia severity (g = 0.94), subjective and objective sleep onset latency (g = 0.65 and g = 0.51, respectively), subjective waking after sleep onset (g = 0.61), subjective and objective sleep efficiency (g = 0.83 and g = 0.48, respectively), and sleep quality (g = 0.80), but was small for health-related QoL (g = 0.34) compared with a control group. At follow-up, the effect sizes of CBT-I were large for all outcome variables, but several large and significant heterogeneities were confirmed. CBT-I is an effective treatment for reducing the severity of insomnia and important disease-related symptoms of comorbid insomnia.

    AB - Although cognitive behavioral therapy (CBT-I) has been recommended for the treatment of insomnia comorbid with psychiatric disorders and medical diseases, the effectiveness of CBT-I in such cases remains to be established. To fill this gap in the literature, we conducted a meta-analysis on the efficacy of CBT-I in the remediation of insomnia severity, important disease-related symptoms, and quality of life (QoL) in comorbid insomnia. A comprehensive literature search identified 30 randomized controlled trials (RCT) that were eligible for inclusion in the final analyses. Effect sizes were computed with Hedges’g, and study quality was evaluated using the Jadad scale. Analysis revealed that the effect sizes of the treatment were medium to large for important disease-related symptoms (g = 0.60), insomnia severity (g = 0.94), subjective and objective sleep onset latency (g = 0.65 and g = 0.51, respectively), subjective waking after sleep onset (g = 0.61), subjective and objective sleep efficiency (g = 0.83 and g = 0.48, respectively), and sleep quality (g = 0.80), but was small for health-related QoL (g = 0.34) compared with a control group. At follow-up, the effect sizes of CBT-I were large for all outcome variables, but several large and significant heterogeneities were confirmed. CBT-I is an effective treatment for reducing the severity of insomnia and important disease-related symptoms of comorbid insomnia.

    KW - Cognitive behavioral therapy

    KW - Comorbid insomnia

    KW - Meta-analysis

    KW - Randomized controlled trial

    UR - http://www.scopus.com/inward/record.url?scp=85040105305&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85040105305&partnerID=8YFLogxK

    U2 - 10.1007/s41105-017-0124-8

    DO - 10.1007/s41105-017-0124-8

    M3 - Article

    AN - SCOPUS:85040105305

    VL - 16

    SP - 21

    EP - 35

    JO - Sleep and Biological Rhythms

    JF - Sleep and Biological Rhythms

    SN - 1446-9235

    IS - 1

    ER -